Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 3, 2008, Pages

  Gamé, Xavier ^a   Allard, Julien ^a   Escourrou, Ghislaine ^a   Gourdy, Pierre ^a   Tack, Ivan ^a   Rischmann, Pascal ^a   Arnal, Jean François ^a   Malavaud, Bernard ^a  

^a CHU RANGUEIL   (France)

Author keywords

Estrogen; Neurourology; Urethra

Indexed keywords

7 NITROINDAZOLE; ESTRADIOL; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MICTURITION; MOUSE; MUSCLE TONE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESIDUAL VOLUME; URETHRA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; ESTRADIOL; ESTRUS; FEMALE; INDAZOLES; MICE; MICE, INBRED C57BL; MUSCLE TONUS; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE I; ORGAN SIZE; OVARIECTOMY; URETHRA; URINARY BLADDER; URINATION;

EID: 40449117963     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00467.2007     Document Type: Article

References (34)

1. Albertazzi P, Sharma S. Urogenital effects of selective estrogen receptor modulators: a systematic review. Climacteric 8: 214-220, 2005.
2. Alexander BT, Miller MT, Kassab S, Novak J, Reckelhoff JF, Kruckeberg WC, Granger JP. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension 33: 435-439, 1999.
3. Al-Hijji J, Batra S. Downregulation by estrogen of nitric oxide synthase activity in the female rabbit lower urinary tract. Urology 53: 637-641, 1999.
4. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074, 1997.
5. Burnett AL, Calvin DC, Chamness SL, Liu JX, Nelson RJ, Klein SL, Dawson VL, Dawson TM, Snyder SH. Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans. Nat Med 3: 571-574, 1997.
6. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92: 722-727, 1998.
7. Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 83: 892-897, 2004.
8. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 12: 15-20, 2001.
9. Carlberg KA, Fregly MJ, Fahey M. Effects of chronic estrogen treatment on water exchange in rats. Am J Physiol Endocrinol Metab 247: E101-E110, 1984.
10. Elhage R, Arnal JF, Pieraggi MT, Duverger N, Fievet C, Faye JC, Bayard F. 17β-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 17: 2679-2684, 1997.
11. Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, Laurell H, Leite-de-Moraes M, Dy M, Arnal JF, Bayard F, Herbelin A. Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-γ production by invariant natural killer T cells. Blood 105: 2415-2420, 2005.
12. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG. Effects of estrogen with and without progestin on urinary incontinence. JAMA 293: 935-948, 2005.
13. Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 12: 258-261, 2001.
14. Ho KM, Ny L, McMurray G, Andersson KE, Brading AF, Noble JG. Co-localization of carbon monoxide and nitric oxide synthesizing enzymes in the human urethral sphincter. J Urol 161: 1968-1972, 1999.
15. Iosif S, Ingemarsson I, Ulmsten U. Urodynamic studies in normal pregnancy and in puerperium. Am J Obstet Gynecol 137: 696-700, 1980.
16. Lin AD, Levin R, Kogan B, Whitbeck C, Chichester P, Sokol R, Mannikarottu A. Estrogen induced functional hypertrophy and increased force generation of the female rabbit bladder. Neurourol Urodyn 25: 473-479, 2006.
17. Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions. Steroids 67: 15-24, 2002.
18. Mamas MA, Reynard JM, Brading AF. Nitric oxide and the lower urinary tract: current concepts, future prospects. Urology 61: 1079-1085, 2003.
19. Modder UI, Riggs BL, Spelsberg TC, Fraser DG, Atkinson EJ, Arnold R, Khosla S. Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur J Endocrinol 151: 503-510, 2004.
20. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 43: 109-142, 1991.
21. Moore PK, Babbedge RC, Wallace P, Gaffen ZA, Hart SL. 7-Nitroindazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br J Pharmacol 108: 296-297, 1993.
22. Norton P, Brubaker L. Urinary incontinence in women. Lancet 367: 57-67, 2006.
23. Okuno T, Masuda H, Tsujii T, Kihara K, Yamauchi Y, Azuma H. Accumulated endogenous nitric oxide synthase inhibitors in inhibiting urethral relaxation following estrogen supplementation in ovariectomized rabbits. J Urol 172: 360-364, 2004.
24. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 62: 45-51, 2003.
25. Shapiro E. Effect of estrogens on the weight and muscarinic cholinergic receptor density of the rabbit bladder and urethra. J Urol 135: 1084-1087, 1986.
26. Stelck RL, Baker GL, Sutherland KM, Van Winkle LS. Estrous cycle alters naphthalene metabolism in female mouse airways. Drug Metab Dispos 33: 1597-1602, 2005.
27. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev: CD001500, 2003.
28. Sutherland RS, Kogan BA, Piechota HJ, Bredt DS. Vesicourethral function in mice with genetic disruption of neuronal nitric oxide synthase. J Urol 157: 1109-1116, 1997.
29. Takahashi W, Yoshida M, Wada Y, Goto S, Inadome A, Yono M, Ueda S. Effect of estrogen on nitric oxide-induced relaxation of the rabbit urethra. Eur J Pharmacol 339: 165-171, 1997.
30. Traish AM, Kim NN, Huang YH, Min K, Munarriz R, Goldstein I. Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res 15: 397-404, 2003.
31. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128, 2001.
32. Van Geelen JM, Doesburg WH, Thomas CM, Martin CB Jr. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol 141: 384-392, 1981.
33. Warembourg M, Leroy D, Jolivet A. Nitric oxide synthase in the guinea pig preoptic area and hypothalamus: distribution, effect of estrogen, and colocalization with progesterone receptor. J Comp Neurol 407: 207-227, 1999.
34. Yamaleyeva LM, Gallagher PE, Vinsant S, Chappell MC. Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2 Lewis rats. Am J Physiol Regul Integr Comp Physiol 292: R819-R826, 2007.